Shows
Lung Cancer ConsideredLung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung CancerIn this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America Conference on Lung Cancer.
Dr. Igor Odintsov discusses updates in diagnostic pathology, including the integration of next-gen sequencing into the patient's journey. Dr. Byoung Chul Cho shares data from the phase 3 trial of gotistobart vs. docetaxel in patients with metastatic squamous cell lung cancer. Dr. Sulin Wu shares insights on the role of family history in lung cancer among women and low-exposure smokers.
2025-12-1637 min2025-08-2638 minLung Cancer ConsideredIASLC Lung Cancer Considered in RomanianIASLC Lung Cancer Considered in Romanian by IASLC
2025-08-0135 min2025-07-2957 minLung Cancer ConsideredPreview: IASLC | ASCO 2025 North American Conference on Lung CancerOn December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the University of Washington and Senior Vice President of the Fred Hutchinson Cancer Center and Dr. Kristen Marrone, Associate Professor of Oncology and Director of the Medical Oncology and Hematology Fellowship Program at Johns Hopkins University.
2025-07-2322 min2025-07-0845 minLung Cancer ConsideredLCC in Cantonese: WCLC24 HighlightsThe 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary.
To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Sally Lau moderates a discussion in Cantonese Chinese about highlights from the conference with Dr. David Lee and Dr. Molly Li.
2025-03-0925 minLung Cancer ConsideredIASLC Lung Cancer Considered in GermanDescription: As part of IASLC’s commitment to communicating in all world languages, this episode of Lung Cancer Considered is recorded in German and is part of our Virtual Tumor Board series. Host Professor Alessandra Curioni-Fontecedro moderates a discussion with two colleagues, who will discuss the dynamic topic of managing resectable stage III NSCLC.
Host: Prof Alessandra Curioni-Fontecedro, MD, Head of Oncology, Cantonal Hospital Fribourg, Chair of Medical Oncology, University of Fribourg
Guest: Prof. Isabelle Opitz, Professor of Thoracic Surgery and Director of the Department of Thoracic Surgery at University Hospital of Zurich, Chair of the Lung Cancer Center of Zu...
2025-01-2252 minLung Cancer ConsideredNinth Edition of Tumor, Node and Metastasis (TNM) Classification SystemIn this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests preview the publication of the Ninth Edition of Tumor, Node and Metastasis (TNM) Classification System for lung cancer. The new edition will be published in January 2025 and has some important changes that reflect an evolving understanding of the disease and more rigorous analysis of data from around the world.
Guest: Dr. Valerie Rusch is a Thoracic Surgeon from Memorial Sloan Kettering Cancer CenterMSKCC where she is Vice Chair for Clinical Research in the Department of Surgery and the Miner Family Chair in Intrathoracic Cancers. She has held...
2024-11-2935 minLung Cancer ConsideredIASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2Title: IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC (recorded on 10/21)
Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu previews the upcoming IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC. To discuss this exciting new meeting and this topic, he is joined by the four co-chairs of the meeting. To learn more about the meeting, visit https://www.httr2024-iaslc.org/.
Guest: Dr. Alice Berger is an Associate Professor in the Human Biology Division and the Herbold Computational Biology Program at the Fred Hutchinson Cancer Center...
2024-10-2923 minLung Cancer ConsideredLCC in Arabic: WCLC 2024 HighlightsThe 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Nagla Abdel Karim moderates a discussion in Arabic about highlights from the conference with Dr. Fawzi Abu Rous, Dr. Raid Aljumaily, Dr. Abdulaziz AlJassim, and Dr. Ashraf Mohamed.
Host:
Dr. Nagla Abdel Karim
Thoracic Medical Oncologist, Director of Developmental Therapeutics at Inova Schar Cancer Institute
Professor of Medicine at the University of Vi...
2024-09-2729 minLung Cancer ConsideredIASLC - ACLC 2024 PreviewIn this episode of Lung Cancer Consider, host Dr. Stephen Liu previews the upcoming IASLC 2024 Asia Conference on Lung Cancer with meeting co-chair, Dr. Feng-Ming (Spring) Kong.
2024-09-1822 minLung Cancer ConsideredLCC in Portuguese: WCLC 2024 HighlightsThe 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Clarissa Mathias moderates a discussion in Portuguese about highlights from the conference with Dr. Isabella Favato Barcelos and Dr. William Nassib William.
Guests:
Dr. Clarissa Mathias
Medical Oncologist at Oncoclinicas Bahia and Hospital Santa Izabel
Dr. Isabella Favato Barcelos
Medical Oncologist, Oncoclinicas&Co/MedSir, Brazil
Dr. William Nassib William
National Leader of Th...
2024-09-1231 minLung Cancer ConsideredLCC in Spanish: WCLC 2024 HighlightsThe 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Coral Olazagasti moderates a discussion in Spanish about highlights from the conference with Dr. Maria Velez and Dr. Rossana Ruiz.
Guests:
Dr. Coral Olazagasti
Assistant Professor at the Sylvester Cancer Center, University of Miami at Miami, Florida.
Dr. Rossana Ruiz
Medical Oncologist from Universidad Peruana Cayetano Heredia Global Health Fellowship at MGH in...
2024-09-1124 minLung Cancer ConsideredLCC in Mandarin: WCLC 2024 HighlightsThe 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin about highlights from the conference with Dr. Huijuan Wang and Dr. Lin Wu.
Guests:
Dr. Chunxia Su
Professor of Oncology at Tongji University
Deputy Director of Medical Oncology at Shanghai Pulmonary Hospital
Dr. Huijuan Wang
Professor of Oncology Department of Medical Oncology
The Affiliated Cancer Ho...
2024-09-1026 minLung Cancer ConsideredLCC in Korean: WCLC 2024 HighlightsThe 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Jii Bum (Joy) Lee.
Guests:
Dr. Chul Kim, MD
Associate Professor at Georgetown University with a focus on thoracic oncology
Dr. Jeongmin Seo, MD
Clinical Assistant Professor at Seoul National University Bundang Hospital with a...
2024-09-0925 minLung Cancer ConsideredWith Eyes On The Future IASLC 50th AnniversaryDescription: To celebrate IASLC’s 50th Anniversary, IASLC produced podcasts looking at our past and present. In this podcast, host Dr. Narjust Florez peers into the future with a detailed discussion of the new IASLC Strategic Plan and how it will impact IASLC as well as the future of lung cancer care.
Guest: Dr. Nick Pavlakis is a thoracic medical oncologist and professor of medicine at the University of Sydney.
Guest: Dr. Gilberto Lopes is the Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, Associate Director for the Cancer Center and Medical Director for International Affairs an...
2024-09-0341 minLung Cancer ConsideredIASLC's 50th Anniversary: The IASLC TodayDescription: This year marks the 50th anniversary of the International Association for the Study of Lung Cancer and as part of this celebratory year, we are looking at the past, present and future of the organization. In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests focus on IASLC today – and some of the ongoing efforts of the IASLC and its members.
Guest: Dr. Christian Rolfo, Professor of Medicine, Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at the Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University.
Guest: Ja...
2024-08-2741 minLung Cancer ConsideredIASLC - The First DecadeIn 1972, in response to the overwhelming need for collaboration and a growing concern for public health, Drs. David T. Carr, Oleg S. Selawry, Lawrence Broder, Clifton Mountain and George Higgins began building an international, multidisciplinary organization. In 1974, the group launched the International Association for the Study of Lung Cancer (IASLC) at their first formal meeting in Florence, Italy, having recruited more than 250 founding members from across the globe and with different perspectives. In today’s episode, host Dr. Narjust Florez talks with two of those early members who played influential roles in IASLC’s early growth and success: Dr. Paul Bunn...
2024-08-2052 minLung Cancer ConsideredIASLC - WCLC 2024 PreviewDescription: In this episode of Lung Cancer Considered, host (and WCLC 2024 Co-Chair) Dr. Narjust Florez previews the upcoming IASLC 2024 World Conference on Lung Cancer with the meeting’s other three co-chairs. Guest: Dr. Linda Martin, Professor of Surgery and Chief of Thoracic Surgery at the University of Virginia. Guest: Dr. Fabio Ynoe de Moraes, Chief of Global Radiation Oncology and Associate Professor of Radiation Oncology at Queen University. Guest: Dr. Sandip Patel, Professor of Medicine and Thoracic Medical Oncologist at the University of California San Diego.
2024-08-1342 minLung Cancer ConsideredIASLC - Spanish Episode Neoadjuvant Therapies In NSCLCIn this episode of Lung Cancer Considered, host Dr. Narjust Florez moderates a discussion in Spanish about perioperative chemotherapy and immunotherapy and how recent research may affect clinical decision making in Latin America.
Guest: Dr. Clarissa Baldotto graduated from the Fluminense Federal University and studied Clinical Oncology at the National Cancer Institute (INCA). She completed a Master's Degree in Clinical Cancerology at INCA and a PhD in Medical Sciences at the D'Or Institute for Research and Education (ID'Or).
Guest: Dr. Paula Ugalde Figueroa graduated from the School of Medicine at the Federal University of Bahia in Salvador, BA, Brazil. With...
2024-08-0946 minLung Cancer ConsideredIASLC - ASCO 2024 Summary--Part 1Title: ASCO 2024 Highlights Part 1 - Plenary
Description: ASCO 2024 had so much lung cancer data, two podcast episodes are required to cover all the data presented. In this first episode, hosts Dr. Stephen Liu and Dr. Narjust Florez cover the LAURA trial, the ADAURA trial, the KRYSTAL-12 study, the phase III EVOKE-01 trial, the phase III ADRIATIC trial, and the REACH-PC trial.
Guest: Dr. David Spigel is the Chief Scientific Officer at Sarah Cannon Research Institute and recipient of the IASLC Heine H. Hansen Lectureship for SCLC.
Guest: Dr. Lecia Sequist is the Program Director for Cancer Early Detection & Diagnostics at...
2024-06-1148 minLung Cancer ConsideredIASLC DEI Initiative Global Member SurveyAs part of the IASLC’s 2024 DEI Initiative, the association is gathering member insights through an online survey and a series of virtual focus groups designed to help the organization better understand the challenges and areas for opportunity facing the global thoracic oncology profession. To take the survey, visit: https://www.iaslc.org/support-mission/iaslc-dei-initiative-global-member-surve
2024-04-1627 minLung Cancer ConsideredLCC in Cantonese Chinese: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Sally Lau leads a discussion in Cantonese about barriers to biomarker testing with Dr. Herbert Loong and Dr. Molly Li. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1639 minLung Cancer ConsideredLCC in Mandarin Chinese: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 which found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin about biomarker testing with Dr. Bo Zhu and Dr. Yuan Li. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1628 minLung Cancer ConsideredLCC in French: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for biomarker tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Alfredo Addeo discussed barriers to biomarker testing in French with Dr. Solange Peters and Dr. Maurice Perol. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1639 minLung Cancer ConsideredLCC in Portuguese: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Clarissa Mathias leads a discussion in Portuguese about biomarker testing with Dr. Vladmir Lima and Dr. Aknar Calabrich. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1636 minLung Cancer ConsideredLCC in French Canadian: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Norman Blais moderates a discussion about biomarker testing in French Canadian with Dr. Arielle Elkrief and Dr. Nicolas Marcoux. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1645 minLung Cancer ConsideredLCC in Japanese: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To promote the survey to a global audience, IASLC has recorded podcast episodes on this topic in different languages. In this episode, host Dr. Misako Nagasaka leads a discussion in Japanese about biomarker testing with Dr.Terufumi Kato and Dr. Masahiro Tsuboi. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1433 minLung Cancer ConsideredLCC in Spanish: Barriers to Biomarker TestingToday, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a global audience, IASLC has recorded podcast episodes on this topic in different languages. To discuss the importance of this survey and its underlying issues, host Dr. Narjust Florez discusses some of the barriers to biomarker testing in Spanish with Dr. Ivy Riano and Dr. Teresa Gorría. To take the survey, visit: https://bit.ly/BiomarkerS24
2024-02-1038 minLung Cancer ConsideredThe IASLC’s 50th Anniversary and New Strategic Plan2024 is the 50th anniversary of the International Association for the Study of Lung Cancer and as we enter this monumental year for IASLC, we do so under a new strategic plan. To discuss what the future of IASLC looks like, hosts Dr. Stephen Liu and Dr. Narjust Florez interview four IASLC leaders to provide a glimpse into where the association is headed.
2024-02-0637 minLung Cancer ConsideredMeet the New IASLC Chief Scientific Officer Dr. Jennifer KingHost Dr. Narjust Florez interviews new IASLC Chief Scientific Officer Dr. Jennifer King. In this podcast episode, Dr. King shares her perspective on how she intends to direct, guide,
and support the scientific strategy of the IASLC.
2024-01-3039 minLung Cancer ConsideredIASLC Chronic Toxicity From Targeted TherapyIASLC Chronic Toxicity From Targeted Therapy by IASLC
2023-12-1955 minLung Cancer ConsideredTitle: Gender Equity and Beyond, a discussion with HRH Princess Dina Mired of JordanFrom lung cancer in women to gender equity in the healthcare workforce, IASLC is privileged to host HRH Princess Dina Mired of Jordan at the 2023 World Conference on Lung Cancer. In this special episode of Lung Cancer Considered, host Dr. Narjust Florez, IASLC President Dr. Heather Wakelee, and WCLC 2023 co-chair Dr. Fiona Hegi-Johnson discuss global advocacy through a gender equity lens, lessons learned from the field, and how HRH Dina Mired’s experience as the mother of a cancer survivor has impacted her work and initiatives globally.
2023-09-091h 00Lung Cancer ConsideredIASLC Hot Topic in Basic and Translational Science Meeting PreviewThis episode of Lung Cancer Considered previews the upcoming IASLC Hot Topic in Basic and Translational Science Meeting on Resistance to Immunotherapy in NSCLC. Joining host Dr. Stephen Liu are:
Guests:
Dr. Joachim Aerts, Professor of Pulmonary Oncology at Erasmus University Rotterdam and Head of Pulmonary Medicine at Erasmus MC in the Netherlands.
Dr. Kellie Smith, Associate Professor of Oncology at Johns Hopkins University.
Dr. Roberto Ferrara, Medical Oncologist and Immunologist, from Istituto Nazionale dei Tumori di Milano in Milan, Italy.
2023-08-0421 minLung Cancer ConsideredIASLC - LCC in Italian: Updates in Resectable NSCLCIASLC - LCC in Italian: Updates in Resectable NSCLC by IASLC
2023-03-3152 minLung Cancer ConsideredIASLC - SCLC 2023 Meeting PreviewIn this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a conversation about small cell lung cancer and previews the upcoming IASLC 2023 Hot Topic Meeting: Small Cell Lung Cancer in April which is focused on both preclinical and clinical advances in small cell lung cancer research. Joining the conversation are Alvaro Quintanal-Villalonga, PhD., from the Rudin Lab at Memorial Sloan Kettering Cancer Center in New York, and Kate Sutherland, PhD., from the Walter and Eliza Hall Institute of Medical Research in Australia.
2023-03-2424 minLung Cancer ConsideredIASLC - NeoadjuvantIn this Virtual Tumor Board episode of Lung Cancer Considered, host Dr. Stephen Liu and his guests discuss the dynamic topic of managing resectable stage III NSCLC. Joining him are:
Dr. Isabelle Schmitt-Opitz, Professor of Thoracic Surgery and Director of the Department of Thoracic Surgery at University Hospital of Zurich, Chair of the Lung Cancer Center of Zurich, and the President of the European Society of Thoracic Surgery. She received the IASLC Robert J Ginsberg Lectureship Award for Surgery at the 2022 World Conference on Lung Cancer.
Dr. Jonathan Spicer, Medical Director of the Thoracic Oncology Program at McGill University in...
2023-03-0745 minLung Cancer ConsideredIASLC - LALCA HighlightsThe Latin American Conference on Lung Cancer, held in Uruguay, wrapped up in late January. To provide a summary of key findings from the meeting, Lung Cancer Considered host Dr. Narjust Florez interviewed two prominent oncologists from South America:
Dr. Clarissa Mathias, Dr. Mathias is a medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quality Steering Group and Lung cancer committee. Dr. Mathias served on the IASLC board and has led many efforts in thoracic oncology in Brazil and recently hosted an episode of Lung Cancer Considered in Portuguese.
Dr. Carlos...
2023-02-0736 min
Lung Cancer ConsideredWCLC 2022 Daily Highlights (Spanish Version) - August 8Destacados Diarios WCLC 2022 - 8 de Agosto
Es el tercer día de la Conferencia Mundial IASLC 2022 sobre Cáncer de Pulmón! La Dra. Narjust Florez recibe a dos investigadores fundamentales: El Dr. Mariano Provencio y La Dra. Enriqueta Felip, para discutir sus estudios mejor calificados.
2022-08-0912 minLung Cancer ConsideredWCLC 2022 Daily Highlights - August 8It’s Day 3 at the IASLC 2022 World Conference on Lung Cancer! Dr. Narjust Florez hosts pivotal researchers Dr. Enriqueta Felip, Dr. Mariano Provencio, and Dr. Rachael Murray to discuss their top-rated studies. IASLC President Dr. Heather Wakelee also joins in to give insight on how the committee selected these high-ranked abstracts for this year’s Presidential Symposium.
2022-08-0840 minLung Cancer ConsideredWCLC 2022 Daily Highlights - August 7In this special edition of Lung Cancer Considered recorded at the IASLC 2022 World Conference on Lung Cancer, hosts Dr. Narjust Florez and Dr. Stephen Liu interview researchers Dr. Chi-Fu Jeffrey Yang, Dr. Jarushka Naidoo and Mr. Koen de Nijs, PhD student, to discuss their recent findings from the significant studies presented today.
2022-08-0723 minLung Cancer ConsideredWCLC 2022 Preview with Meeting Chairs Robert Pirker and Silvia NovelloToday's podcast originates from the IASLC World Conference on Lung Cancer in Vienna. Hosts Dr. Stephen Liu and Dr. Narjust Florez interview IASLC WCLC 2022 Honorary Chair Dr. Robert Pirker and Chair Dr. Silvia Novello at the meeting. Dr. Pirker and Dr. Novello provide an overview of the meeting and give podcast listeners a glimpse of what to expect at the IASLC WCLC 2022.
2022-08-0616 minLung Cancer ConsideredIASLC Fellowship Grants With Grace Dy Fred Hirsch And Jarushka NaidooOn this episode of Lung Cancer Considered, three past IASLC Fellowship Grants winners share their own stories of how these grants helped propel their careers. Hosted by Dr. Narjust Florez, guests include:
Dr. Grace Dy is an associate professor of medicine at Department of Medicine at Jacobs School of Medicine & Biomedical Sciences at the University of Buffalo and a medical thoracic oncologist at Roswell Park Cancer Center. Dr. Dy received an IASLC fellowship grant in 2007.
Fred R. Hirsch, MD, PhD, is Executive Director at the Center for Thoracic Oncology in The Tisch Cancer Institute at Mount Sinai (TCI) and the...
2022-08-0240 minLung Cancer ConsideredWCLC 2022 Preview With Narjust Florez And Stephen LiuThe IASLC World Conference on Lung Cancer will be held in person this year in Vienna. Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu preview the meeting highlights and provide advice on how to plan your own experience and what scientific sessions might be the most interesting. This podcast episode is a must listen for all in person attendees and those participating virtually from their home or office.
2022-07-2623 minLung Cancer ConsideredWomen In Thoracic Oncology With Prunella Blinman And Clarissa MathiasIn this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of the unique challenges women in oncology face as they navigate career pathways. She is joined by Dr. Prunella Blinman, a medical oncologist at Concord Repatriation General Hospital in Sydney, Australia and clinical associate professor at the University of Sydney. Also joining the discussion is Dr. Clarissa Mathias, medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quality Steering Group and Lung cancer committee and she served on the IASLC board of directors.
2022-07-1938 minLung Cancer ConsideredLung Cancer in Germany with Alessandra Curioni Martin Reck and Juergen WolfeIn keeping with IASLC's international focus, this episode of Lung Cancer Considered focuses on the state of lung cancer in Germany. This episode is hosted by Dr. Alessandra Curioni, Thoracic Medical Oncologist at the University of Zurich and her guests are two of the most prominent lung cancer experts in Germany -- Dr. Martin Reck, Head of the Department of Thoracic Oncology and the Head of the Clinical Trials Department at the Lung Clinic Grosshansdorf and Dr. Juergen Wolf, Medical Director for the Center for Integrated Oncology at the University Hospital Cologne.
2022-07-1236 minLung Cancer ConsideredSmoking Cessation And Stigma With Jamie Ostroff Matthew Steliga And Jim PantelasProviding smoking cessation without contributing to the stigma faced by those who smoke is a worthwhile goal. To discuss this in greater detail, Lung Cancer Considered host Dr. Narjust Duma welcomes Dr. Jamie Ostroff, Dr. Matthew Steliga, and Jim Pantelas. Dr. Ostroff is the Joseph Gaumont Chair of Cancer Prevention and the Director of the Memorial Sloan Kettering Tobacco Treatment Program and Dr. Steliga is an Associate Professor in Surgery at the University of Arkansas Medical Center and a member and past chair of the IASLC Tobacco control and smoking cessation committee. Mr. Jim Pantelas is a patient advocate and...
2022-05-1743 min
Lung Cancer ConsideredClimate Change and Lung Cancer With Joan Schiller and Eric BernickerOn a special Earth Day episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by two vocal IASLC members who have taken a passionate interest in understanding more about the climate crisis and how it impacts our patients with lung cancer.
2022-04-2248 minLung Cancer ConsideredLung Cancer Considered 100th Episode - Interview with new IASLC CEO, Dr. Karen KellyIn the 100th episode of IASLC's Lung Cancer Considered, host Dr. Narjust Duma interviews new IASLC CEO, Dr. Karen Kelly. Dr. Kelly is recognized internationally for her expertise in lung cancer research and her career has been dedicated to providing enhanced cancer care through innovative and groundbreaking clinical trials. Dr. Kelly’s lung cancer research has involved all aspects of the disease from risk reduction to screening to treatment. She has been at the forefront of drug development to treat lung cancer for decades. Dr. Kelly is the first female to hold this post in the association’s almost 50-year hist
2022-04-1938 minLung Cancer ConsideredTargeted Therapies of Lung Cancer with Charu Aggarwal Lecia Sequist and Ivy ElkinsThe IASLC Targeted Therapies Meeting has historically been a very interactive, fast-paced meeting that highlights the latest and most innovative anticancer drugs, initially focused on targeted agents but in recent years, extending to immunotherapy.
In this Lung Cancer Considered podcast hosts Dr. Narjust Duma and Dr. Stephen Liu lead a wide-ranging discussion of the meeting with three lung cancer experts who attended the meeting:
Dr. Lecia Sequist is a thoracic medical oncologist at Massachusetts General Hospital, the Landry Family Professor of Medicine at Harvard Medical School, the Director of the Center for Innovation in Early Cancer Detection and a board...
2022-03-0148 minLung Cancer ConsideredIASLC Stars - Lillian Leigh, Erika Hlavacek, Caleb EgwuenuIn this new episode of Lung Cancer Considered, podcast host Dr. Narjust Duma interviews three IASLC Patient Research Advocates who are part of the IASLC Supportive Training for Advocates on Research & Science (STARS) program: Caleb Egwuenu comes from Nigeria and participated in STARS for two years as a Patient Research Advocate: Erika Hlavacek, a Patient Research Advocate and founder of nonprofit yEAHbestlife from Illinois; and Lillian Leigh, STARS mentor from Australia.
2021-12-0140 minLung Cancer ConsideredGlobal Advocacy - Dr. Anne-Marie BairdGlobally, lung cancer is the single most lethal cancer, accounting for 1.8 million deaths last year, yet research funding devoted to lung cancer pales in comparison to other cancer types. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses how global advocacy might play a role in addressing this gap. His guest is Dr. Anne-Marie Baird, a cancer researcher at Trinity College in Dublin, Ireland. Dr. Baird is the former Chair of the IASLC Communications Committee, and the newly appointed President of Lung Cancer Europe, a European platform for lung cancer advocacy.
2021-11-3029 minLung Cancer ConsideredSCLC Research - Charles Rudin and Tripnara SenThis episode of Lung Cancer Considered looks ahead to the IASLC 2021 Hot Topic Meeting on Small Cell Lung Cancer, scheduled for Oct 29th and 30th 2021. Host Dr. Stephen Liu discusses the state of the SCLC research with Dr. Tripnara Sen, an Assistant Attending Biologist in the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and Dr. Charles Rudin, the co-director of the Druckenmiller Center for Lung Cancer Research and the Sylvia Hassenfeld Chair in Lung Cancer Research, also from Memorial Sloan Kettering.
2021-10-2626 minLung Cancer Considered2021 WCLC Highlights: Higgins, Harpole and StinchcombeThe IASLC 2021 World Conference on Lung Cancer co-chairs Dr. David Harpole, Dr. Kristin Higgins, Dr. Thomas Stinchcombe join Lung Cancer Considered Hosts Dr. Narjust Duma and Dr. Stephen Liu to cover highlights of the recently concluded virtual meeting. Tune in to hear these IASLC members discuss the most significant research developments from the conference.
2021-09-1545 min
Lung Cancer VoicesEp 40. Throwback - Patient Programs at the IASLC: Get Involved!In this throwback episode with the 2021 International Association for the Study of Lung Cancer conference taking place, Dr. Paul Wheatley-Price interviews Kirsten Ito, Associate Director, IASLC Foundation and Patient Advocacy, about the opportunities for patient involvement with the IASLC. Registration to the 2021 virtual conference, taking place now until Sept 14, 2021, is free for patients and caregivers. Registration link: https://wclc2021.iaslc.org/registration/.
2021-09-1014 min
Lung Cancer VoicesThrowback - Patient Programs at the IASLC: Get Involved!In this throwback episode with the 2021 International Association for the Study of Lung Cancer conference taking place, Dr. Paul Wheatley-Price interviews Kirsten Ito, Associate Director, IASLC Foundation and Patient Advocacy, about the opportunities for patient involvement with the IASLC. Registration to the 2021 virtual conference, taking place now until Sept 14, 2021, is free for patients and caregivers. Registration link: https://wclc2021.iaslc.org/registration/.
2021-09-1014 minLung Cancer ConsideredMeet Our President and President Elect - Heather Wakelee and Paul Van SchilIn this episode of Lung Cancer Considered , Dr. Heather Wakelee and Dr. Paul Van Schil join hosts Dr. Narjust Duma and Dr. Stephen Liu to discuss priorities and initiatives for IASLC in the 2021-22 year. Dr. Wakelee takes the reins as President of the IASLC this month during WCLC, the second woman to achieve this honor. Dr. Van Schil begins his term as President-Elect of the IASLC during WCLC, too.
2021-09-0742 minLung Cancer ConsideredELCC Highlights - Felip and BarlesiThis edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC:
Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy cohorts
CheckMate 9LA -- randomized 719 patients with EGFR/ALK wild type NSCLC to standard chemotherapy or 2 cycles of chemotherapy with nivolumab and Ipilimumab
KEYNOTE-407-- randomized squamous NSCLC to carboplatin with choice of nab/ paclitaxel or paclitaxel, and either pembrolizumab or placebo
AMG 757...
2021-04-0526 min
Lung Cancer ConsideredDeveloping the Moderna COVID-19 VaccineThis special episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and co-host Paul Bunn. Dr. Liu and Dr. Bunn are joined by, Dr. Tal Zaks, the chief medical officer at Moderna, and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the University of Colorado Cancer Center, former president of IASLC and ASCO. Dr. Moore serves as the director of Science and Research for the GO2 Foundation for Lung Cancer. Together, they discuss the development of the Moderna COVID-19 vaccine what lung cancer patients, doctors and advocates should...
2021-03-0854 min
VJOncology PodcastThe Lung Cancer Sessions: highlights from IASLC WCLCVJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights from the IASLC World Conference on Lung Cancer (WCLC), which was held virtually in January 2021.
Daniel Tan (National Cancer Centre Singapore, Singapore) is joined by Melissa Johnson (Sarah Cannon Research Institute, TN) and Dean Fennell (University Hospitals of Leicester NHS Trust, UK), who offer their perspectives on the exciting data and what research could change practice in the future.
Tune in to this podcast to learn about the latest advances in KRAS G12C inhibitors...
2021-02-1846 minLung Cancer ConsideredWCLC 2020 Highlights and Wrap-UpLung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma are joined by Dr. Ross Soo, a senior consultant in the Department of Hematology-Oncology at the National University of Cancer Institute Singapore to discuss highlights from the IASLC 2020 WCLC Singapore meeting. Dr. Soo, along with Dr. Yi-Long Wu and Dr. Daniel Tan, served as co-chair of the meeting. Together Dr. Liu, Dr. Duma and Dr. Soo discuss key science, highlights, benefits and challenges of the virtual meeting.
2021-02-0241 minLung Cancer ConsideredTips and Tricks for Navigating IASLC WCLCLung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma share highlights, tips and tricks for navigating IASLC's World Conference on Lung Cancer Singapore this year. Listen to this podcast as you prepare for the world’s leading lung cancer event (held virtually January 28 – 31). Register for IASLC's WCLC at //wclc2020.iaslc.org/registration.
2021-01-1825 minLung Cancer ConsideredWomen In Thoracic OncologyThe latest episode of Lung Cancer Considered discusses women in thoracic oncology and the upcoming IASLC Women in Thoracic Oncology Event. Register now for this event. This episode features a conversation between host, Dr. Narjust Duma, and Dr. Heather Wakelee and Dr. Clarissa Mathias. Dr. Wakelee is a thoracic medical oncologist, Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology at Stanford University Medical Center. She is also the president-elect of the IASLC. Dr. Clarissa Mathias, Medical Oncologist at Grupo Oncoclinicas, is president of the Brazilian Society of Medical Oncology, Chair of the ASCO...
2021-01-1225 minLung Cancer ConsideredThrowback to WCLC 2019In the latest episode of Lung Cancer Considered, we're going back to October 2019, pre-COVID, when Dr. Jack West interviewed Dr. Tony Mok about highlights and new research from the 2019 IASLC World Conference on Lung Cancer. We’re feeling nostalgic about being able to meet in person and heartened by how far we’ve come since our last time together.
2020-10-0521 minLung Cancer ConsideredEquity in MedicineIn the latest episode of Lung Cancer Considered, three experts in thoracic oncology from around the world discuss and share their stories and experience about diversity and equity in medicine. This episode features a conversation between Dr. Narjust Duma, assistant professor of medicine - thoracic oncology at the University of Wisconsin Carbone Cancer Center; Dr. Jhanelle Gray, chair of the department of thoracic oncology and program co-leader for chemical biology and molecular medicine at the Moffitt Cancer Center; and Dr. Clarissa Mathias, Brazilian Society of Medical Oncology president, IASLC Board Member, Chair of the ASCO International Committee and Medical Oncologist...
2020-09-2153 minLung Cancer ConsideredIASLC Hot Topics on Liquid BiopsyThe latest episode of Lung Cancer Considered focuses on the upcoming IASLC Liquid Biopsy Meeting that will discuss the current status of liquid biopsy in the field of thoracic. This episode features a conversation between Dr. David Gandara, director of thoracic oncology, professor emeritus, and senior advisor to the director at the UC Davis Comprehensive Cancer Center; Dr. Maria Arcila, director of the diagnostic molecular pathology laboratory at Memorial Sloan Kettering Cancer Center; and Dr. Christian Rolfo, director of the thoracic medical oncology and early clinical trials at the University of Maryland Comprehensive Cancer Center (UMGCCC), a professor in the...
2020-08-1728 minLung Cancer ConsideredThe IASLC Pathology Committee’s Creation of the IHC AtlasThe latest episode of Lung Cancer Considered focuses on the IASLC Pathology Committee's creation of the Immunohistochemistry (IHC) Atlas. This episode features a conversation between host Dr. Sanja Dacic, a professor in the department of pathology at the University of Pittsburg Medical Center in Pennsylvania; Dr. Keith Kerr, professor of pulmonary pathology at Aberdeen University Medical School and a consultant pathologist at the Aberdeen Royal Infirmary in Scotland; and Dr. Yasushi Yatabe, chief of the department of diagnostic pathology at the National Cancer Center in Toyko, Japan.
2020-08-0335 minLung Cancer ConsideredPros and Cons of TelemedicineThe latest episode of Lung Cancer Considered focuses on a recent article in the IASLC Lung Cancer News publication about the pros and cons of telemedicine. This episode features a conversation between host Dr. Jack West and Dr. Mary Jo Fidler, associate professor of medical oncology at Rush Medical University Center in Chicago and Dr. Sandip Patel, associate professor of medical oncology at the University of California at San Diego.
2020-07-2024 minLung Cancer ConsideredADAURA: A Lively Debate Among Key VoicesThe latest episode of Lung Cancer Considered focuses on the research from the ADAURA trial that came out of ASCO 2020. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani; Dr. Nathan Pennell, professor of medicine and director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute; Dr. Jack West, an associate clinical professor in medical oncology, a specialist in thoracic oncology and executive director of employee services at City of Hope of Comprehensive Cancer Center; and Jill Feldman, lung cancer patient, patient advocate and co-founder of the group EGFRResisters.
2020-07-0640 minLung Cancer ConsideredTumor Mutational Burden and COVID19 – A Pathologist’s PerspectiveThe latest episode of Lung Cancer Considered focuses on a recent publication in IASLC's Journal of Thoracic Oncology that features new guidelines on Tumor Mutational Burden as well as the effects of COVID-19. This episode features a conversation between host Dr. Marty Edelman; Dr. Lynette Scholl an associate professor of Pathology at Harvard Medical School and an associate pathologist, Pathology at Brigham And Women's Hospital; and Dr. John Longshore director of Molecular Pathology at Carolinas Pathology Group, Atrium Health, Carolinas HealthCare System.
2020-06-2931 min
Lung Cancer ConsideredAmerican Society of Clinical Oncology Virtual Meeting HighlightsThe latest episode of Lung Cancer Considered focuses on lung cancer research presented at the American Society of Clinical Oncology virtual meeting this past weekend. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani and Dr. Stephen Liu, associate professor at the Lombardi Cancer Center at Georgetown University School of Medicine.
2020-06-0444 minLung Cancer ConsideredIASLC Radiation Oncology and COVID-19 Webinar RecapThe latest episode of Lung Cancer Considered features a conversation between host Dr. Jack West and Dr. Corinne Faivre-Finn, professor of thoracic radiation oncology and honorary consultant clinical oncologist at the Christie National Health Service Foundation Trust in the United Kingdom and Dr. Walter J. Curran, Jr., executive director of the Winship Cancer Institute of Emory University and the Lawrence W. Davis professor and chairman of the Emory Department of Radiation Oncology. The podcast focuses on radiation oncology, lung cancer and COVID-19.
2020-06-0132 minLung Cancer ConsideredWhat Patients Need to Know About Lung Cancer Research in the Era of COVID-19The newest episode of Lung Cancer Considered, the IASLC's official podcast program, features patient advocates and lung cancer researchers on what patients need to know about lung cancer research in the era of COVID-19. This episode features a conversation between Janet Freeman-Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat); Jill Feldman, lung cancer advocate and patient; Dr. Alice Berger, assistant professor of human biology at the Fred Hutchinson Cancer Research Center; Dr. Christine Lovly, associate professor of medicine, division of Hematology and Oncology and Ingram Associate Professor of Cancer Research...
2020-05-2640 minLung Cancer ConsideredAround The World: COVID-19 and Lung Cancer Tips and ExperiencesThe newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on a discussion between lung cancer experts from the U.S. and Europe discussing COVID-19 with regard to lung cancer patients with experiences, results and actions from different parts of the world. This episode features a conversation between Dr. Marty Edelman, chair of department of hematology/oncology and a professor, department of hematology/oncology at Fox Chase Cancer Center; Dr. Leora Horn, Ingram associate professor of cancer research at Vanderbilt Ingram Cancer Center and clinical director, thoracic oncology program; and Dr. Solange Peters, professor and chair of...
2020-05-1851 minLung Cancer ConsideredHow To Find Information on COVID-19 In Different Regions- Spanish LanguageThe newest episode of Lung Cancer Considered, the IASLC's official podcast program, is a Spanish language podcast focusing on the use of telemedecine during this time and how lung cancer patients can find information in different regions of the world. This episode features a conversation between Dr. Narjust Duma, assistant professor of medicine, thoracic oncologist at the University of Wisconsin; Dr. José Corona-Cruz, thoracic surgical oncologist at the Instituto Nacional de Cancerología in México; and Dr. Antonio Calles, medical oncologist in the Division of Medical Oncology at the Hospital General Universitario Gregorio Marañón in Madrid, Spain.
2020-05-0437 minLung Cancer ConsideredCOVID-19 Guidelines for Patients with Lung Cancer with Dr. Erin BangeThe newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on a collection of journal articles and guidelines about COVID-19 in patients with lung cancer. This episode features a conversation between IASLC Chief Science Officer, Dr. Chandra Belani and Dr. Erin Bange, oncology fellow of the University of Pennsylvania School of Medicine.
2020-04-2729 minLung Cancer ConsideredJTO Study on Smoking Cessation Impact with Dr. Rafael MezaThe newest episode of Lung Cancer Considered, the IASLC's official podcast program, focuses on the recent Journal of Thoracic Oncology study, "Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States." This episode features a conversation between Dr. Jack West and Dr. Rafael Meza, associate professor in the department of epidemiology and co-leader of the cancer epidemiology and prevention program at the University of Michigan Rogel Cancer Center.
2020-04-2024 min
Lung Cancer Voices14. Kristin Ito - Patient Programs at the IASLCIn this episode, Dr. Paul Wheatley-Price speaks to Kirstin Ito, Patient Advocacy Manager at the International Association for the Study of Lung Cancer about how patients can get involved in their programs. Note that the programs mentioned in the podcast have an application deadline of Mar 27, 2020.
https://www.iaslc.org/
2020-03-2014 minLung Cancer ConsideredInterview with IASLC President- Dr. Tetsuya MitsudomiThis episode features a conversation between Dr. Marty Edelman, Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology at Fox Chase Cancer Center and IASLC President, Dr. Tetsuya Mitsudomi, a Professor at the Division of Thoracic Surgery, Department of Surgery at Kindai University Faculty of Medicine in Osaka-Sayama, Japan. Together they discuss highlights of Dr. Mitsudomi's career, his goals as President of IASLC and what his hopes are for the future of lung cancer research.
2020-03-1622 minLung Cancer ConsideredHighlights from 20th IASLC 2020 Lung Cancer Targeted Therapies ConferenceThis episode features Dr. Marty Edelman, Chair of the Department of Hematology/Oncology and a Professor, Department of Hematology/Oncology at Fox Chase Cancer Center. He is joined by Dr. Roy Herbst, a Professor of Medicine and Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center/ Yale School of Medicine; and Dr. Leora Horn, the Ingram Associate Professor of Cancer Research at Vanderbilt Ingram Cancer Center and Clinical Director, Thoracic Oncology Program. Together they discuss highlights from the 20th IASLC 2020 Lung Cancer Targeted Therapies conference in Santa Monica
2020-03-0221 minLung Cancer ConsideredIASLC 2020 Lung Cancer Targeted Therapies MeetingThis episode features Janet Freeman- Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat), she is joined by Dr. Paul Bunn, a distinguished professor and Dudley Endowed Chair at the University of Colorado Comprehensive Cancer Center and IASLC Past President and Past CEO; as well as Dr. Suresh Ramalingam, Roberto Goizueta Chair in Cancer Research, Winship Cancer Institute of Emory University. Together they discuss the upcoming IASLC 2020 Lung Cancer Targeted Therapies meeting in Santa Monica.
2020-02-1724 minLung Cancer ConsideredInterview with IASLC Chief Science Officer Dr. Chandra BelaniThis episode features a conversation between Dr. Heather Wakelee, Professor of Medicine in the Division of Oncology at Stanford University and faculty director of the Stanford Cancer Clinical Trials Office and current president-elect of the IASLC and Dr. Chandra Belani, professor of Medicine in the Division of Hematology/Oncology in the Department of Medicine at the Penn State Hershey Medical Center in Hershey, Penn. The interview covers Dr. Belani’s new position as chief science officer for the IASLC and the history of his involvement with lung cancer.
2020-02-0425 min
Lung Cancer ConsideredAmerican Cancer Society Report with CSO Dr. Chandra BelaniThis episode features a conversation between Dr. Heather Wakelee, professor of Medicine in the Division of Oncology at Stanford University and faculty director of the Stanford Cancer Clinical Trials Office and current president-elect of the IASLC and Dr. Chandra Belani, professor of Medicine in the Division of Hematology/Oncology at the Penn State Hershey Medical Center in Hershey, Penn., and the chief science officer for the IASLC. Together they discuss a recent study from the American Cancer Society that reported a significant drop in the cancer mortality rate, led largely by progress in lung cancer.
2020-01-2116 min
Lung Cancer ConsideredE-Cigarette and Vaping Policy with Dr. Matthew SteligaThis episode features a conversation between David Mesko, the chief executive officer of IASLC and Dr. Matt Steliga, chair of The IASLC Tobacco Control and Smoking Cessation Committee and surgical oncologist at Winthrop P. Rockefeller Cancer Institute, Little Rock, Ark. The two discussed the e-cigarettes and vaping and IASLC’s leadership on this developing public health issue.
2020-01-0718 min
Lung Cancer ConsideredCT Lung Cancer Screening with First Responders with Dr. Vershalee ShuklaDr. Vershalee Shukla, radiation oncologist at the Vincere Cancer Center in Scottsdale, Ariz., joins Dr. Jack West to discuss what led her to pursue research on lung cancer for first responders that she presented at the IASLC 2019 North American Conference on Lung Cancer in Chicago.
2019-12-0212 min
Lung Cancer ConsideredLung Cancer Research Trends in France with Dr. Benjamin Besse at IASLC 2019 WCLCDr. Benjamin Besse, medical oncologist and head of thorocacic onoclogy program at the Institut Gustave Roussy, France, joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain discuss lung cancer research trends in France.
2019-11-1819 min
Lung Cancer ConsideredWomen Leaders in Lung Cancer with Dr. Heather Wakelee and Professor Corinne Faivre-FinnDr. Heather Wakelee thoracic medical oncologist and professor of medicine at Stanford University Medical Center and president-elect of IASLC and Corinne Faivre-Finn professor of thoracic radition oncology at the University of Manchester in the UK and honorary consultant clinical oncologist joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain to discuss women leadership in oncology and medicine.
2019-10-2823 min
Lung Cancer ConsideredIASLC 2019 WCLC Highlights with Dr. Tony MokDr. Tony Mok, Li Shu Fan Medical Foundation professor of clinical oncology in the department of Clinical Oncology at the Chinese University of Hong Kong, joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain discuss highlights and new research from the conference. Dr. Mok is a past president of IASLC.
2019-10-1421 min
Lung Cancer ConsideredLung Cancer Trends in Australia with Dr. Ben Solomon at IASLC 2019 WCLCDr. Benjamin Solomon, lead investigator and medical oncologist at Peter MacCallum Cancer Centre, Melbourne, Australia joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain to discuss his journey to thoracic oncology, why he chose to focus on Alk+ Non- Small Cell Cancer and lung cancer trends Australia.
2019-09-3016 min
Lung Cancer ConsideredLung Cancer Trends in Europe with Clinical Chief Dr. Rami PortaDr. Ramon Rami Porta, Clinical Chief of the Department of Thoracic Surgery at Hospital Universitari Mútua Terrassa, in Terrassa (Barcelona), Spain, joins Dr. Jack West for a discussion on the importance of lung cancer tumor staging, the status of CT Screening for lung cancer prevention in Europe and a preview of the IASLC World Conference on Lung Cancer in Barcelona. Listen to the end to get some tips on Barcelona culture, food and a great tip for waking up in the morning after a late dinner!
2019-09-0224 min
Lung Cancer ConsideredState Of Mesothelioma Treatment With Dr. Anne TsaoDr. Jack West is joined by Dr. Anne Tsao for a conversation on the state of treatment of mesothelioma in anticipation of the first IASLC 2019 Mesothelioma Meeting July 10-12, 2019 in New York, NY. Dr. Tsao is Professor in the Department of Thoracic Head and Neck Medical Oncology in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston. She is also Director of the Mesothelioma Program and Director of the Thoracic Chemo Radiation program.
2019-07-0611 min
West Wind (Audio)Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLCLecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors.
2019-06-1723 min
West Wind (Video)Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLCLecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors.
2019-06-1723 min
Lung Cancer ConsideredIASLC President-Elect Elections: Introducing Candidate Dr. Heather WakeleeIASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. Heather Wakelee, Professor of Medicine, Oncology at Stanford University in Stanford, California. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.
2019-05-3021 min
Lung Cancer ConsideredIASLC President-Elect Elections: Introducing Candidate Dr. William TravisIASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. William Travis, Attending Thoracic Pathologist at Memorial Sloan Kettering Cancer Center in New York. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.
2019-05-3019 min
Lung Cancer ConsideredIASLC President-Elect Elections: Introducing Candidate Dr. Pasi JanneIASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. Pasi Janne, a translational thoracic medical oncologist at the Dana Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He is also the Director of the Lowe Center for Thoracic Oncology and the Director of the Belfer Center for Applied Cancer Science. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.
2019-05-3015 min
Lung Cancer ConsideredBlood Based Testing And The Evolution Of Lung Cancer With Dr. David GandaraDr. Jack West is joined by Dr. David Gandara to discuss blood based testing for molecular interrogation, blood based assays for tumor mutational burden, and how the landscape of lung cancer and the IASLC have evolved. Dr. Gandara is Professor of Medicine and Senior Adviser to the Director of Medical Oncology at University of California Davis in Davis, CA and past president of the IASLC.
2019-05-2021 min
Lung Cancer ConsideredA Conversation With IASLC President, Giorgio ScagliottiDr. Jack West is joined by IASLC president Dr. Giorgio Scagliotti for discussions on strategic goals of the IASLC and the evolution of staging efforts, the evolution in treating non-squamous non-small cell lung cancer, the status of screening efforts in Europe, and how patients are playing an active role in the study of lung cancer.
2019-04-1518 min
Lung Cancer ConsideredThe Evolution of Small Cell Lung CancerDr. Jack West is joined by Dr. Christine Hann and Dr. Stephen Liu for a discussion on the advancement of therapies in small cell lung cancer. Lung Cancer Considered is the podcast of the International Association for the Study of Lung Cancer (IASLC).
2019-03-2820 min